References
- Kikutani H., Makino S. The murine autoimmune diabetes model: NOD and related strains. Adv. in Imunol. 1992; 51: 285–322
- Tochino Y. The NOD mouse as a model of type I diabetes. Crit. Rev. Immunol. 1987; 8: 49–81
- Charlton B., Bacelj A., Slattery R. M., Mandel T. E. Cyclophosphamide‐induced diabetes in NOD/WEHI mice. Evidence for suppression in spontaneous autoimmune diabetes mellitus. Diabetes. 1989; 38: 441–447
- Kay T. W., Campbell I. L., Harrison L. C. 1991. Characterization of pancreatic T lymphocytes associated with beta cell destruction in the non‐obese diabetic (NOD) mouse. J. Autoimmunity. 1991; 4: 263–276
- Miyazaki A., Hanafusa T., Yamada K. Predominance of T lymphocytes in pancreatic islets and spleen of pre‐diabetic non‐obese diabetic (NOD) mice: a longitudinal study. Clin. Exp. Immunol. 1985; 60: 622–630
- Signore A., Pozzilli P., Gale A., Andreani D., Beverley P. C. The natural history of lymphocyte subsets infiltrating the pancreas of NOD mice. Diabetologia. 1989; 32: 282–289
- Christianson S. W., Shultz L. D., Leiter E. H. Adoptive transfer of diabetes into immunodeficient NOD‐scid/scid mice. Relative contributions of CD4 + and CD8 + T‐cells from diabetic versus prediabetic NOD. NON‐Thy‐la donors. Diabetes. 1993; 42: 44–55
- Yasunami R., Bach J. F. Anti‐suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice. Eur. J. Immunol. 1988; 18: 481–484
- Reich E. P., Scaringe F., Yagi J., Sherwin R. S., Janeway C. J. Prevention of diabetes in NOD mice by injection of autoreactive T‐lymphocytes. Diabetes. 1989; 38: 1647–1651
- Chosich N., Harrison L. C. Suppression of diabetes mellitus in the non‐obese diabetic (NOD) mouse by an autoreactive (anti‐I‐Ag7) islet‐derived CD4+ T‐cell line. Diabetologia. 1993; 36: 716–721
- Hutchings P. R., Cooke A. The transfer of autoimmune diabetes in NOD mice can be inhibited or accelerated by distinct cell populations present in normal splenocytes taken from young males. J. Autoimmunity. 1990; 3: 175–185
- Boitard C., Yasunami R., Dardenne M., Bach J. F. T cell‐mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J. Exp. Med. 1989; 169: 1669–1680
- Mosmann T. R., Schumacher J. H., Street N. F. Diversity of cytokine synthesis and function of mouse CD4+ T cells. Immunol. Rev. 1991; 123: 209–229
- Moore K. W., O'Garra A., de Waal M. R., Vieira P., Mosmann T. R. Interleukin‐10. Annu. Rev. Immunol. 1993; 11: 165–90
- Hsieh C. S., Macatonia S. E., Tripp C. S., Wolf S. F., O'Garra A., Murphy K. M. Development of TH1 CD4+ T cells through IL‐12 produced by Listeria‐induced macrophages. Science 1993; 260: 547–549
- Sher A., Coffman R. L. Regulation of immunity to parasites by T cells and T cell‐derived cytokines. Ann. Rev. Immunol. 1992; 10: 385–409
- Reed S. G., Scott P. T‐cell and cytokine responses in leishmaniasis. Current opinion in immunol. 1993; 5: 524–531
- Morris L., Troutt A. B., Handman E., Kelso A. Changes in the precursor frequencies of IL‐4 and IFN‐gamma secreting CD4 + cells correlate with resolution of lesions in murine cutaneous leishmaniasis. J. Immunol. 1992; 149: 2715–2721
- Honeyman M. C., Harrison L. C. The immunologic insult in type 1 diabetes. Semin. Immunopathol. 1993; 5: 253–274
- Bach J. 1994. Insulin‐dependent diabetes mellitus as an autoimmune disease. Endocrine Rev. 1994; 15: 516
- Shehadeh N. N., LaRosa F., Lafferty K. J. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J. Autoimmunity. 1993; 6: 291–300
- Baxter A. G., Koulmanda M., Mandel T. E. High and low diabetes incidence non obese diabetic (NOD) mice: origins and characterisation. Autoimmunity. 1993; 9: 61–67
- Faulkner‐Jones B. E., Cram D. S., Kun J., Harrison L. C. Localisation and quantitation of expression of two gutamate decarboxylase genes in pancreatic β‐cells and other peripheral tissues of mouse and rat. Endocrinology. 1993; 133: 2962–2972
- Foley K. P., Leonard M. W., Engel J. D. Quantitation of RNA using the polymerase chain reaction. TIG. 1993; 9: 380–385
- Faulkner‐Jones B. E. Of sweet mice, stiff men and cytokines. Analysis of the expression patterns of glutamate decarboxylase and T‐lymphocyte cytokines with emphasis on their relevance to insulin dependent diabetes mellitus. PhD. thesis, University of Melbourne, Australia 1994
- Dallman M. J., Montgomery R. A., Larsen C. P., Wanders A., Wells A. F. Cytokine gene expression: analysis using northern blotting, polymerase chain reaction and in situ hybridization. Immunol. Rev. 1991; 119: 163–79
- Kennedy M. K., Torrance D. S., Picha K. S., Mohler K. M. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomylitis reveals that IL‐10 mRNA expression correlates with recovery. J. Immunol. 1992; 149: 2496–505
- Anderson J. T., Cornelius J. G., Jarpe A. J., Winter W. E., Peck A. B. Insulin‐dependent diabetes in the NOD mouse model II. β‐cell destruction in autoimmune diabetes is a TH2 and not a TH1 mediated event. Autoimmunity. 1993; 15: 113–22
- Rothe H., Faust A., Schade U., Kleemann R., Hibino T., Martin S., Kolb H. Cyclophosphamide treatment of female non‐obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon‐gamma, but not of interleukin‐4. Diabetologia. 1994; 37: 1154–1158